
Realief™ Neuropathy Centers offers patented, data-backed treatments for peripheral neuropathy, aiming to bring real relief nationwide.
Biolyst, operating as Realief™ Neuropathy Centers, is dedicated to providing innovative pain management solutions for peripheral neuropathy. Their mission is to alleviate symptoms such as pain, numbness, tingling, burning, and balance issues through a proprietary treatment protocol backed by clinical data. With locations across the United States, including North Carolina, South Carolina, Wisconsin, Minnesota, Arizona, and Nevada, Realief™ aims to deliver effective, individualized care nationwide.
Realief™ Neuropathy Centers have achieved significant milestones by publishing validated data from an extensive patient registry and conducting peer-reviewed, randomized, placebo-controlled, double-blind clinical trials. Their commitment to evidence-based treatments sets them apart in the field of neuropathy care. The centers' continuous improvement of treatment protocols ensures they remain at the forefront of neuropathy therapy, providing real relief to countless patients.

Global Pain Center

Neuright
neurightlabs.com

NeuroTherapeutics Pharma

WinSanTor
winsantor.com

NeuraLace Medical

Neuropathix
neuropathix.com

Relevium Medical
Neuropure
Pacira BioSciences
pacira.com

Alleviate

Medx Back Pain Clinics.
medx.clinic

Neuraptive Therapeutics
neuraptive.com

4e Therapeutics

Neuraly
neuralymed.com

American Pain Consortium
Companies similar to Biolyst include Global Pain Center, Neuright, NeuroTherapeutics Pharma and WinSanTor.
Biolyst was founded in 2010.
Biolyst's headquarters is located in Brooklyn Park, MN, US.
Biolyst's most recent funding round was for $458k (USD) in August 2013.
As of Aug 1, 2013, Biolyst has raised a total of $458k (USD).
Biolyst has 6 employees as of Feb 5, 2024.